Product Information
METOPROLOL SUCC ER 100 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0850 per EA under NDC 68382056601. Its NADAC has been published 418 times since Oct 3, 2018.
FDA first approved this application on Mar 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382056601
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA203894FDA Approved
3/23/2018
TE Code
AB
On Market Since
6/7/2018
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 100 MG TAB has been published 418 times since Oct 3, 2018, and over the history we have for it it has declined 70.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0850 per EA |
|---|---|
| All-time high | $0.2903 (Nov 14, 2018) |
| All-time low | $0.0813 (Apr 22, 2026) |
| 52-week high | $0.0966 |
| 52-week low | $0.0813 |
| Median price | $0.1490 |
| Average price | $0.1587 |
| Largest weekly change | +47.2% (Mar 20, 2024) |
| Weeks tracked | 418 |
| Tracking since | Oct 3, 2018 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metoprolol succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 100 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0850 per EA (NDC 68382056601), effective Sep 30, 2026.
How has the price of METOPROLOL SUCC ER 100 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 100 MG TAB has declined 70.6%. It has been tracked across 418 weekly CMS publications since Oct 3, 2018.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 100 MG TAB?
Since Oct 3, 2018, the NADAC for METOPROLOL SUCC ER 100 MG TAB has ranged from a low of $0.0813 (Apr 22, 2026) to a high of $0.2903 (Nov 14, 2018), with a median of $0.1490 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 100 MG TAB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOPROLOL SUCC ER 100 MG TAB, is $0.0813 per EA — about 4% below METOPROLOL SUCC ER 100 MG TAB.
Who manufactures METOPROLOL SUCC ER 100 MG TAB?
METOPROLOL SUCC ER 100 MG TAB (NDC 68382056601) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.